Ozempic Ingredients: What’s Actually in the Shot — and Why It Matters

Most men who ask about Ozempic ingredients are really asking a deeper question: is this thing real medicine, or is it overhyped? The answer is in the molecule itself. Ozempic’s active ingredient is semaglutide — a synthetic analog of glucagon-like peptide-1 (GLP-1), a hormone your gut naturally releases after eating. That single ingredient has now accumulated one of the most impressive clinical evidence portfolios in modern metabolic medicine.

A 2025 cohort study published in JAMA Network Open tracking over 23,000 real-world semaglutide patients found that initiating the drug was significantly associated with a 3.8% reduction in body weight at 13–24 months, alongside meaningful drops in diastolic blood pressure, systolic blood pressure, and total cholesterol. Those aren’t placebo numbers. They reflect what happens when a precisely engineered peptide hits the right receptor with sustained force.

The Active Ingredient: Semaglutide in Detail

Semaglutide is a 94% sequence-identical analog to human GLP-1, modified at two amino acid positions and attached to a fatty acid chain that binds albumin in the bloodstream. That structural tweak is what gives it a half-life of roughly seven days — long enough to sustain receptor activation from a single weekly injection. In contrast, your body’s natural GLP-1 degrades in under two minutes. The pharmaceutical version is engineered for durability.

The inactive ingredients in the Ozempic pen — sodium phosphate dibasic dihydrate, propylene glycol, phenol, and water for injection — serve as stabilizers and preservatives that keep the peptide viable in solution. These are standard pharmaceutical excipients with well-established safety profiles. The drug is supplied at concentrations of 0.25 mg, 0.5 mg, and 1 mg per dose, with titration designed to minimize the gastrointestinal side effects that come with GLP-1 receptor activation.

Wegovy, the higher-dose sibling formulation of semaglutide at 2.4 mg/week, recently received accelerated FDA approval in August 2025 for a new indication — treating metabolic dysfunction-associated steatohepatitis (MASH) with moderate-to-advanced fibrosis. According to updated AASLD Practice Guidance published in Hepatology, 72 weeks of treatment achieved resolution of MASH in 62.9% of patients versus 34.3% on placebo — a result that has fundamentally changed how hepatologists think about fatty liver disease management. The active ingredient is identical between Ozempic and Wegovy; the difference is dose and approved indication.

What Semaglutide Does — and What It Doesn’t Do for Your Body Composition

Understanding the ingredient means understanding its mechanism. Semaglutide slows gastric emptying, reduces appetite signaling in the hypothalamus, and improves insulin sensitivity. What it does not do is selectively burn fat while preserving lean mass. That distinction matters enormously for men who care about how they look and perform, not just what the scale reads.

This is where training and nutrition become non-negotiable partners to the medication. A 2024 retrospective analysis in Nutrients found that obesity and metabolic syndrome were among the strongest negative predictors of anabolic response to resistance exercise and protein supplementation in older men — confirming that metabolic dysfunction actively blunts muscle-building signals. If semaglutide helps you lose significant weight but you’re not resistance training and eating adequate protein, you risk trading fat for muscle alongside it. The drug handles appetite. You handle the gym.

This is also why the counterfeit and gray-market semaglutide problem is worth taking seriously. Research published in The Annals of Pharmacotherapy documented online vendors selling vials labeled “for research purposes only” — semaglutide and tirzepatide products sold without prescriptions, often without proper reconstitution supplies, and with no quality verification. You have no way of knowing whether those vials contain the right active ingredient, the right concentration, or anything sterile at all. Similarly, a 2026 study in the same journal examined 25 transdermal “natural GLP-1” patch products — all illegal under the Dietary Supplement Health and Education Act, most lacking certificates of analysis, and many drawing one- and two-star reviews from consumers reporting no effect. Berberine, cinnamon, and pomegranate are not semaglutide. They are not going to replicate its mechanism, no matter how cleverly they’re marketed.

The Takeaway

Ozempic’s power lives entirely in one molecule: semaglutide. Everything else in the pen is there to keep that molecule stable and deliverable. If you’re considering this medication, what matters most is getting it through a legitimate prescriber who can assess whether you’re a candidate, monitor for risks like pancreatitis or gallbladder disease, and help you pair it with the resistance training and protein intake that will protect your muscle mass through the process. The ingredient is real. The results are real. But they belong inside a complete strategy — not as a standalone fix.